October 6, 2006

Lee National Denim Day® Results in Multi-Million Dollar Gift for the Women's Cancer Programs of the Entertainment Industry Foundation

$5.5 million will be directed towards groundbreaking early detection and treatment research as well as breast cancer prevention services

Merriam, Kan. - Today, a check for $5.5 million was donated to the Women's Cancer Programs of the Entertainment Industry Foundation (EIF) on behalf Lee National Denim Day, the largest single-day fundraiser for breast cancer, founded by Lee Jeans 11 years ago. Millions of people across the country wore denim today in exchange for a $5 donation for breast cancer early detection and treatment research and breast cancer prevention services.

Actress Gabrielle Union, a 2006 Lee National Denim Day ambassador, attended the celebration at Lee Jeans' headquarters on behalf of EIF. Union is participating in Denim Day in honor of a close friend recently diagnosed with breast cancer. Lisa Paulsen, president and CEO of EIF, accepted the check for the charity along with special guests who will help put the funds to use, namely Dr. Dennis Slamon, Director of Clinical/Translational Research, UCLA and Chair of EIF's National Women's Cancer Research Alliance (NWCRA), and Fran Visco, president of the National Breast Cancer Coalition Fund.

"Lee National Denim Day is about camaraderie - millions of people coming together, symbolically wearing denim and making a small donation, that when combined, has a tremendous impact in the fight against breast cancer," said Liz Cahill, director of public relations and advertising at Lee Jeans. "It's thrilling to feel that teamwork come to life on Denim Day when we announce the funds raised and provide details on how they will be put to work by a host of leading institutions."

Net proceeds from Lee National Denim Day will support groundbreaking early detection and treatment research and support community breast cancer prevention services. Specifically, Denim Day funds will help establish the Lee Jeans Translational Laboratories and Fellowships for Breast Cancer Research; support the EIF Breast Biomarker Discovery Project, a multi-year effort by world-class scientists to develop a blood test for early detection of breast cancer; and create web-based and print resources for the National Breast Cancer Coalition that will offer individuals with breast cancer evidence-based information about diagnosis and treatment options.

"The Entertainment Industry Foundation is proud to join Lee Jeans for Lee National Denim Day. Together we are committed to funding the most promising and groundbreaking breast cancer treatment and early detection research in the country," said Paulsen.

Since the program's inception in 1996, millions of people have participated in Lee National Denim Day at companies, schools and through local civic groups. Nearly 20,000 companies participated in the 11th year of the program, which raised more than $61 million in its first 10 years.

Lee® Jeans is a division of VF Corporation (NYSE: VFC). Headquartered in Merriam, Kan., Lee manufactures and markets brand denim, casual pants, shirts, fleece and knit apparel. A brand committed to the community, Lee Jeans founded Lee National Denim Day®, the largest single-day fundraiser for breast cancer. VF Corporation is a leader in branded apparel including jeanswear, outdoor products, intimate apparel, image apparel and sportswear. Its principal brands include Lee®, Wrangler®, Riders®, Rustler®, Vanity Fair®, Vassarette®, Bestform®, Lily of France®, Nautica®, John Varvatos®, JanSport®, Eastpak®, The North Face®, Vans®, Reef®, Napapijri®, Kipling®, Lee Sport® and Red Kap®.

The Entertainment Industry Foundation (EIF), as a leading charitable organization of the entertainment industry, has distributed hundreds of millions of dollars to support charitable initiatives addressing critical health, education and social issues.

EIF is committed to saving lives by raising awareness about the importance of early detection of breast and reproductive cancers, and providing funds to advance early detection and treatment research, as well as support to community programs that assist the millions of women and their families at risk of or affected by cancer.

Through EIF's National Women's Cancer Research Alliance and EIF's Revlon Run/Walk For Women, EIF funds some of the most promising research being conducted today to develop new and more effective approaches to the treatment of women's cancers. EIF grants helped accelerate research that led to a treatment breakthrough-the development of Herceptin®, the first successful drug that seeks out a particular gene found in one of three cases of the most aggressive form of breast cancer. EIF grants have also supported other state-of-the-art therapies bringing new and innovative treatment approaches to breast cancer worldwide.

More recently, EIF launched its Women's Cancer Research Fund. Focused on early detection of cancer, the initiative supports EIF's Breast Cancer Biomarker Discovery Project-an ambitious, groundbreaking scientific project where a group of internationally recognized scientists and clinicians are collaborating to develop a blood test that will detect breast cancer in its beginning stages, when survival rates are highest.

For questions about EIF's women's cancer programs and information about breast cancer, visit eifoundation.org or call 800-426-0010.

###

Media Contacts:
Rachel McKenney
816.512.9482
rmckenney@beap.com

Megan Hutchison
816.512.9519
mhutchison@beap.com

Maurine Slutzky
213.240.3923
mslutzky@eifoundation.org